Table 2.
Fatigue severity in Covid-19 and pre-pandemic IMV-patients.
| Covid-19 cohort | Pre-pandemic cohort | p-value | ||
|---|---|---|---|---|
| Total N | — | 18 | 188 | — |
| Fatigue severity at ∼3 months | Median (IQR) | 5.5 (2.0–6.2) | 5.0 (2.8–7.0) | 0.809 |
| Total N | — | 32 | 166 | — |
| Fatigue severity at ∼6 months | Median (IQR) | 2.0 (1.0–5.0) | 5.7 (3.5–7.3) | <0.001 |
| Total N | — | — | 159 | — |
| Fatigue severity at ∼12 months | — | — | 5.0 (3.0–7.0) | — |
| Total N | — | 85 | — | — |
| Fatigue severity across follow-up period | Median (IQR) | 5.0 (2.0–7.0) | — | — |
Fatigue severity according to Visual Analogue Scale in self-reported questionnaires. Covid-19 cohort: ∼3 months—90–120 days, ∼6 months—150–210 days, Fatigue at 12 months was not compared as the Covid-19 cohort had not accrued follow-up to this time point.